TP53 and myelodysplastic syndrome: TP53 mutations in t-MDS are strongly associated with genomic instability; in fact, in TP53-mutant MDS, the frequency of patients with >3 cytogenetic abnormalities is very high, while in TP53-WT patients, it is low [86].